Target Name: PTCHD3P1
NCBI ID: G387647
Review Report on PTCHD3P1 Target / Biomarker Content of Review Report on PTCHD3P1 Target / Biomarker
PTCHD3P1
Other Name(s): Patched domain containing 3 pseudogene 1 | patched domain containing 3 pseudogene 1

Identification and Potential Drug Targets for PDPs

Patched domain containing 3 pseudogenes (PDPs) is a family of non-coding RNA molecules that have been identified in various organisms, including humans. These molecules are characterized by the presence of a patched domain, which is a short sequence of amino acids that is Typically conserved across different species. PDPs have been shown to play important roles in various cellular processes, including gene regulation, DNA replication, and cell signaling.

One of the PDPs identified in humans is PTCHD3P1, which is a pseudogene that encodes a protein known as PRDM3. PRDM3 is a core component of the poly(ADP-ribose) polymerase (PARP) complex, which is a critical enzyme for DNA repair and genome stability. PARP is involved in the repair of DNA double-strand breaks, including those caused by mutations, and is essential for the maintenance of genomic integrity.

The PDP family

PDPs are characterized by the presence of a patched domain, which is a short sequence of amino acids that is typically conserved across different species. The patched domain is thought to be involved in the formation of a protein complex that can interact with other molecules to regulate various cellular processes.

In addition to the patched domain, PDPs typically have multiple conserved amino acid residues that are involved in the formation of a distinct protein structure. These conserved residues include a lysine residue, an amino acid residue involved in protein-protein interactions, and a glycine residue that is often involved in modification of the protein.

Function and potential as a drug target

The function of PDPs is not well understood, but they have been shown to play important roles in various cellular processes. For example, PDPs have been shown to be involved in gene regulation, DNA replication, and cell signaling.

One of the functions of PDPs is their role in regulating gene expression. PDPs have been shown to interact with various transcription factors to regulate gene expression, including factors that control the expression of genes involved in cell signaling and development.

PDPs have also been shown to be involved in DNA replication. PDPs have been shown to interact with DNA replication factors, including the DNA polymerase I (DNAPK), to promote the initiation of DNA replication and ensure the proper completion of the replication process.

In addition to their role in regulating gene expression and DNA replication, PDPs have also been shown to play important roles in cell signaling. For example, PDPs have been shown to interact with various signaling molecules, including proteins involved in cell adhesion, to regulate the formation of cell-cell junctions and the maintenance of tissue architecture.

Given the importance of PDPs in various cellular processes, they have potential as drug targets. The patched domain of PDPs makes them a promising target for small molecules, as these molecules can interact with the protein structure to modulate its function.

In conclusion, PTCHD3P1 is a pseudogene that encodes a protein known as PRDM3. PRDM3 is a core component of the poly(ADP-ribose) polymerase (PARP) complex, which is involved in the repair of DNA double-strand breaks. The PDP family has been shown to play important roles in various cellular processes, including gene regulation, DNA replication, and cell signaling. Given their importance, PTCHD3P1 has potential as a drug target. The patched domain of PDPs makes them a promising target for small molecules, as these molecules can interact with the protein structure to modulate its function. Further research is needed to understand the full function of PTCHD3P1 and its potential as a drug target.

Protein Name: Patched Domain Containing 3 Pseudogene 1

The "PTCHD3P1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PTCHD3P1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

PTCHD3P2 | PTCHD4 | PTCRA | PTCSC2 | PTCSC3 | PTDSS1 | PTDSS2 | PTEN | PTENP1 | PTENP1-AS | PTER | PTF1A | PTGDR | PTGDR2 | PTGDS | PTGER1 | PTGER2 | PTGER3 | PTGER4 | PTGER4P2-CDK2AP2P2 | PTGES | PTGES2 | PTGES2-AS1 | PTGES3 | PTGES3L | PTGES3L-AARSD1 | PTGES3P1 | PTGES3P2 | PTGES3P3 | PTGFR | PTGFRN | PTGIR | PTGIS | PTGR1 | PTGR2 | PTGR3 | PTGS1 | PTGS2 | PTH | PTH1R | PTH2 | PTH2R | PTK2 | PTK2B | PTK6 | PTK7 | PTMA | PTMAP1 | PTMAP5 | PTMAP7 | PTMS | PTN | PTOV1 | PTOV1-AS1 | PTOV1-AS2 | PTP4A1 | PTP4A1P2 | PTP4A2 | PTP4A3 | PTPA | PTPDC1 | PTPMT1 | PTPN1 | PTPN11 | PTPN11P5 | PTPN12 | PTPN13 | PTPN14 | PTPN18 | PTPN2 | PTPN20 | PTPN20A | PTPN20CP | PTPN21 | PTPN22 | PTPN23 | PTPN3 | PTPN4 | PTPN5 | PTPN6 | PTPN7 | PTPN9 | PTPRA | PTPRB | PTPRC | PTPRCAP | PTPRD | PTPRE | PTPRF | PTPRG | PTPRH | PTPRJ | PTPRK | PTPRM | PTPRN | PTPRN2 | PTPRN2-AS1 | PTPRO | PTPRQ | PTPRR